Distinguished Autism Researcher Dies

A child neurologist, Isabelle Rapin popularized the notion that autism was part of a spectrum of disorders.

Written byDiana Kwon
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Isabelle RapinALBERT EINSTEIN COLLEGE OF MEDICINEIsabelle Rapin, a child neurologist who spent her long career advancing the science behind autism spectrum disorder, died of pneumonia last month at age 89 (May 24).

“Calling her one of the founding mothers of autism is very appropriate,” Thomas Frazier II, a clinical psychologist and chief science officer of Autism Speaks, an advocacy group for people with autism and their families, tells The New York Times. “With the gravity she carried, she moved us into a modern understanding of autism.”

Rapin was born in Lausanne, Switzerland, and attended medical school at the University of Lausanne. She moved to Manhattan in 1953, where she worked at both Bellevue Hospital and Columbia-Presbyterian Hospital before taking a position at Albert Einstein College of Medicine in the Bronx.

During her long career, Rapin focused on communication disorders in children and made a number of significant contributions to the field of autism research, such as advancing ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Diana is a freelance science journalist who covers the life sciences, health, and academic life. She’s a regular contributor to The Scientist and her work has appeared in several other publications, including Scientific American, Knowable, and Quanta. Diana was a former intern at The Scientist and she holds a master’s degree in neuroscience from McGill University. She’s currently based in Berlin, Germany.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies